Skip to main content

The Baker Bros Are Back

The most sophisticated Biotech Investors Are Buying a Fresh Breakout

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

📌 Hycroft Mining $HYMC — Eric Sprott disclosed a $5.70 Million Form 4 purchase.
 
Another sizable buy from one of the most influential precious-metals investors. Sprott continues to average up into strength — an unmistakable vote. Check out how we’re trading this name.

📌 Celanese $CE — Chuck Kyrish bought $205,150.
 
A mid-sized insider purchase in a major chemicals producer already trading below its pre GFC highs. 

Here’s The Hot Corner, with data from December 11, 2025:

📌 Genuine Parts $GPC — Rep. Michael McCaul disclosed $100,000 to $250,000 in new purchases.

📌 Kymera Therapeutics $KYMR — The Baker Bros. increased their stake from 9.30% to 10.90%.
 
A significant step-up from biotech’s most respected investors — notable given the name’s recent rally. 

Here’s how we’re trading this name. 

If you want this actionable trade ideas based on insider trading, join Hot Corner Insider risk-free.

KYMR is completing a massive five-year base, after reaching our initial target.

Price is extended in the shorter timeframes, but the primary trend is undeniably higher.

We want to be buyers on a sustained breakout above 90, targeting 140.